The Pharmacy Industry in Porsgrunn: Current Status and Future Prospects

Pharmacy is a vital industry in Porsgrunn, with 9 registered companies and 75 employees as of the latest data. The sector has shown resilience despite fluctuations in sales and employment numbers over the past decade. Key players include established chains like Apotek 1 Svanen and Vitusapotek, alongside newer entrants such as Boots Apotek. While some companies report strong financial metrics (e.g., EBITDA margins of 6–7%), others face challenges, including zero revenue or operational activity. The industry’s stability and alignment with healthcare needs present opportunities for founders considering entry, though competition and market saturation should be carefully evaluated.

Sales Development (2016–2025):

• 2017: A significant drop (-52.1%) to NOK 70.5M, likely due to market consolidation.
• 2018–2023: Steady growth, peaking at NOK 195.7M in 2023 (+2.7% YoY).
• 2024–2025: A temporary dip (-7.0% in 2024) followed by a rebound (+12.5% in 2025).

Wage Development (2016–2026):

• Employees peaked at 87 in 2023, then declined to 67 in 2025 (-10.7% YoY in 2024). The drop may reflect automation or reduced branch operations.

Profitability:

• Average EBITDA margin of 6%, with operating margins around 5%. Companies like Apotek 1 Svanen report higher margins (7%) compared to newer entrants like Vitusapotek Stridsklev (0%).

Porsgrunn has 9 registered companies in the pharmacy industry, primarily structured as AS (7 companies). Key players include:

Notable trends:

• Established chains (e.g., Apotek 1, Vitusapotek) dominate with stable revenue and employee counts.
• Newer entrants (e.g., Boots Apotek, founded 2024) report zero activity, suggesting potential underperformance or early-stage challenges.
• Klikk Holding As (founded 2021) has no revenue but holds NOK 21.0K in equity, indicating possible future activity.

All pharmacy activity in Porsgrunn is concentrated in the municipality itself, with 7 companies and 75 employees reported in the central area. Key locations include:

• Kulltangvegen 70 (Apotek 1 Svanen)
• Augestadvegen 7 (Apotek 1 Hovenga)
• Porselensvegen 14 (Boots Apotek)

The distribution reflects a centralized retail model, with pharmacies clustered in residential and commercial hubs. This concentration may limit expansion opportunities but ensures accessibility for local populations.

Bankruptcies and Insolvencies:

• No pharmacy companies in Porsgrunn are currently bankrupt, though Vitusapotek Stridsklev and Vitusapotek Vestsiden report zero revenue and operational activity. This may indicate temporary closures or rebranding efforts.

Stability and Development:

• Despite fluctuations, the sector has maintained no bankruptcies since 2016, suggesting resilience. However, the decline in employee numbers (-10.7% YoY in 2024) raises questions about long-term sustainability, particularly for newer companies with limited revenue streams.

Outlook for Founders

The pharmacy sector in Porsgrunn offers moderate opportunities for founders, with a stable market and established demand. Key considerations include:

• Market saturation: 9 companies in a single municipality may limit growth for new entrants.
• Profitability potential: Established players like Apotek 1 Svanen achieve EBITDA margins of 7%, suggesting room for efficiency-driven models.
• Regulatory alignment: Strong healthcare infrastructure in Vestfold og Telemark supports long-term viability.

SmartGrunder can help founders find suitable addresses in Porsgrunn for pharmacy operations, with a focus on areas with high population density and existing business structures.

The broader håndverk (craft) industry in Porsgrunn includes 10 companies, compared to 9 in pharmacy. Key differences include:

• Sales growth: Håndverk saw a 12.0% increase in 2025, outpacing pharmacy’s 12.5% growth.
• Peer comparison: Hygea Helse & Bandasje As (sales: NOK 9.6M, EBITDA: NOK 45.0K) represents a related but distinct segment (medical goods retail), highlighting the diversity within håndverk.

While pharmacy and håndverk share similar sales trends, pharmacy’s lower company count and higher EBITDA margins (6% vs. håndverk’s unspecified) suggest a more specialized, less volatile market.

The pharmacy industry in Porsgrunn is a stable, albeit competitive sector with opportunities for founders willing to navigate market saturation. Established players dominate, but the absence of bankruptcies and recent sales growth (2025) indicate resilience. Strategic entry—such as targeting underserved areas or leveraging digital tools—could differentiate new entrants. For local decision-makers, fostering collaboration between pharmacies and healthcare providers may enhance long-term viability. SmartGrunder can assist with detailed analytical tools to identify future potential areas in the municipality.